Figure 4
From: A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo
Pyridone 8 does not affect internalisation of the GSH-R1a receptor.
Representative images are depicted following different treatments: untreated control (assay buffer), ghrelin (1 μM), [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P (SP-analog) (0.1 μM) and pyridone 8 (10 μM). Graph represents the mean ± SEM of quantified fluorescence intensity (15 pictures per treatment) of perinuclear GHS-R1a-EGFP receptor from a representative experiment (for details, see SI).
